Olaris CEO, Dr. Elizabeth O'Day, profiled in HubWeek's Change Marker series

What are Olaris' BoRs and how will they fundamentally change the way diseases are treated? Learn about our Biomarkers of Response and Olaris' mission here! 

March 11, 2020